Overexpression of opioid growth factor (OGF) receptor enhances the growth inhibitory effects of OGF on pancreatic adenocarcinoma and SCCHN

被引：0
|
作者：
McLaughlin, Patricia J. [1 ]
Verderame, Michael F. [1 ]
Zagon, Ian S. [1 ]
机构：
[1] Penn State Univ, Coll Med, Hershey, PA USA
来源：
CANCER RESEARCH | 2006年 / 66卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1645
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Combination chemotherapy with gemcitabine and biotherapy with opioid growth factor (OGF) enhances the growth inhibition of pancreatic adenocarcinoma
    Ian S. Zagon
    Jeffrey R. Jaglowski
    Michael F. Verderame
    Jill P. Smith
    Alphonse E. Leure-duPree
    Patricia J. McLaughlin
    Cancer Chemotherapy and Pharmacology, 2005, 56 : 510 - 520
  • [2] Combination chemotherapy with gemcitabine and biotherapy with opioid growth factor (OGF) enhances the growth inhibition of pancreatic adenocarcinoma
    Zagon, IS
    Jaglowski, JR
    Verderame, MF
    Smith, JP
    Leure-duPree, AE
    McLaughlin, PJ
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2005, 56 (05) : 510 - 520
  • [3] Nucleocytoplasmic distribution of opioid growth factor (OGF) and OGF receptor in rat cornea
    Zagon, IS
    Sassani, JW
    Ruth, TB
    Leure-duPree, AE
    McLaughlin, PJ
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2002, 43 : U363 - U363
  • [4] Expression of Opioid Growth Factor (OGF)-OGF Receptor (OGFr) Axis in Human Nonmedullary Thyroid Cancer
    Goldenberg, David
    Zagon, Ian S.
    Fedok, Fred
    Crist, Henry S.
    McLaughlin, Patricia J.
    THYROID, 2008, 18 (11) : 1165 - 1170
  • [5] Enhanced antitumor activity of paclitaxel on SCCHN with opioid growth factor (OGF): In vitro studies
    McLaughlin, PJ
    Jaglowski, JR
    Stack, BC
    Zagon, IS
    FASEB JOURNAL, 2004, 18 (05): : A997 - A997
  • [6] Diabetic keratopathy and treatment by modulation of the opioid growth factor (OGF)-OGF receptor (OGFr) axis with naltrexone: A review
    McLaughlin, Patricia J.
    Sassani, Joseph W.
    Klocek, Matthew S.
    Zagon, Ian S.
    BRAIN RESEARCH BULLETIN, 2010, 81 (2-3) : 236 - 247
  • [7] Enhanced growth inhibition of human pancreatic cancer cells by opioid growth factor (OGF) and gemcitabine
    Jaglowski, JR
    McLaughlin, PJ
    Smith, JP
    Zagon, IS
    FASEB JOURNAL, 2004, 18 (05): : A997 - A997
  • [8] OPIOID GROWTH FACTOR (OGF) IMPROVES SURVIVAL IN PATIENTS WITH ADVANCED PANCREATIC CANCER
    Smith, J. P.
    Bingaman, S. I.
    Mauger, D. T.
    Harvey, H. A.
    Demers, L. M.
    Zagon, I. S.
    PANCREAS, 2008, 37 (04) : 496 - 496
  • [9] Prospective oncotarget for gynecological cancer: Opioid growth factor (OGF) - opioid growth factor receptor (OGFr) axis
    Qu, Na
    Wang, Xiaobin
    Meng, Yiming
    Shan, Fengping
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2019, 75
  • [10] Immunoelectron microscopic localization of the opioid growth factor receptor (OGFr) and OGF in the cornea
    Zagon, IS
    Ruth, TB
    Leure-duPree, AE
    Sassani, JW
    McLaughlin, PJ
    BRAIN RESEARCH, 2003, 967 (1-2) : 37 - 47
12345